These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 26545695)

  • 1. TREATMENT OF SUBCLINICAL HYPERTHYROIDISM: EFFECT ON BODY COMPOSITION.
    Boj-Carceller D; Sanz-París A; Sánchez-Oriz E; García-Foncillas López R; Calmarza-Calmarza P; Blay-Cortes V; Abós-Olivares MD
    Nutr Hosp; 2015 Nov; 32(5):2331-7. PubMed ID: 26545695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High prevalence of side effects after recombinant human thyrotropin-stimulated radioiodine treatment with 30 mCi in patients with multinodular goiter and subclinical/clinical hyperthyroidism.
    Romão R; Rubio IG; Tomimori EK; Camargo RY; Knobel M; Medeiros-Neto G
    Thyroid; 2009 Sep; 19(9):945-51. PubMed ID: 19678745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normalization of serum thyrotrophin by means of radioiodine treatment in subclinical hyperthyroidism: effect on bone loss in postmenopausal women.
    Faber J; Jensen IW; Petersen L; Nygaard B; Hegedüs L; Siersbaek-Nielsen K
    Clin Endocrinol (Oxf); 1998 Mar; 48(3):285-90. PubMed ID: 9578817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissociation of leptin and body weight in hyperthyroid patients after radioiodine treatment.
    Obermayer-Pietsch BM; Frühauf GE; Lipp RW; Sendlhofer G; Pieber TR
    Int J Obes Relat Metab Disord; 2001 Jan; 25(1):115-20. PubMed ID: 11244466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The assessment of body composition using DEXA in patients with thyroid dysfunction].
    Brunová J; Kasalický P; Lánská V
    Cas Lek Cesk; 2007; 146(5):497-502. PubMed ID: 17554975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Radioiodine treatment of hyperthyroidism using a simplified dosimetric approach. Clinical results].
    Giovanella L; De Palma D; Ceriani L; Vanoli P; Garancini S; Tordiglione M; Tarolo GL
    Radiol Med; 2000 Dec; 100(6):480-3. PubMed ID: 11307510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioiodine therapy compared in patients with toxic nodular or Graves' hyperthyroidism.
    Franklyn JA; Daykin J; Holder R; Sheppard MC
    QJM; 1995 Mar; 88(3):175-80. PubMed ID: 7767667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single, very low dose (0.03 mg) of recombinant human thyrotropin (rhTSH) effectively increases radioiodine uptake in the I-131 treatment of large nontoxic multinodular goiter.
    Mojsak MN; Abdelrazek S; Szumowski P; Rogowski F; Sykała M; Kostecki J; Kociura-Sawicka A; Jurgilewicz D; Myśliwiec J
    Nucl Med Rev Cent East Eur; 2016; 19(1):3-11. PubMed ID: 26841373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thiamazole Pretreatment Lowers the (131)I Activity Needed to Cure Hyperthyroidism in Patients With Nodular Goiter.
    Kyrilli A; Tang BN; Huyge V; Blocklet D; Goldman S; Corvilain B; Moreno-Reyes R
    J Clin Endocrinol Metab; 2015 Jun; 100(6):2261-7. PubMed ID: 25867812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioiodine treatment of hyperthyroidism in patients with low thyroid uptake.
    Ruchała M; Sowiński J; Dolata M; Junik R; Gembicki M; Skiba A
    Nucl Med Rev Cent East Eur; 2005; 8(1):28-32. PubMed ID: 15977144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioiodine therapy in elderly patients with subclinical hyperthyroidism due to non-voluminous nodular goiter and its effect on bone metabolism.
    Rosario PW
    Arq Bras Endocrinol Metabol; 2013 Mar; 57(2):144-7. PubMed ID: 23525293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects on bone mineral density by treatment of benign nodular goiter with mildly suppressive doses of L-thyroxine in a cohort women study.
    Appetecchia M
    Horm Res; 2005; 64(6):293-8. PubMed ID: 16269872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A longitudinal study of changes in body mass index and total body composition after radioiodine treatment for thyrotoxicosis.
    de la Rosa RE; Hennessey JV; Tucci JR
    Thyroid; 1997 Jun; 7(3):401-5. PubMed ID: 9226210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relapses of hyperthyroidism in patients treated with radioiodine for nodular toxic goiter: relation to thyroid autoimmunity.
    Custro N; Ganci A; Scafidi V
    J Endocrinol Invest; 2003 Feb; 26(2):106-10. PubMed ID: 12739735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular assessment of hyperthyroid patients with multinodular goiter before and after radioiodine treatment preceded by stimulation with recombinant human TSH.
    Barca MF; Gruppi C; Oliveira MT; Romão R; Cárdia MS; Rubio I; Knobel M; Medeiros-Neto G
    Endocrine; 2007 Oct; 32(2):175-81. PubMed ID: 18026694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Body weight and body composition changes after treatment of hyperthyroidism.
    Lönn L; Stenlöf K; Ottosson M; Lindroos AK; Nyström E; Sjöström L
    J Clin Endocrinol Metab; 1998 Dec; 83(12):4269-73. PubMed ID: 9851762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in body composition in women following treatment of overt and subclinical hyperthyroidism.
    Greenlund LJ; Nair KS; Brennan MD
    Endocr Pract; 2008 Nov; 14(8):973-8. PubMed ID: 19095595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioiodine 131I treatment for large nodular goiter: recombinant human thyrotropin allows the reduction of radioiodine 131I activity to be administered in patients with low uptake.
    Ceccarelli C; Antonangeli L; Brozzi F; Bianchi F; Tonacchera M; Santini P; Mazzeo S; Bencivelli W; Pinchera A; Vitti P
    Thyroid; 2011 Jul; 21(7):759-64. PubMed ID: 21568727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmune hyperthyroidism occurring late after radioiodine treatment for volume reduction of large multinodular goiters.
    Huysmans AK; Hermus RM; Edelbroek MA; Tjabbes T; Oostdijk ; Ross HA; Corstens FH; Kloppenborg PW
    Thyroid; 1997 Aug; 7(4):535-9. PubMed ID: 9292939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The feasibility of low-dose oral lithium therapy and its effect on thyroidal radioiodine uptake, retention, and hormonal parameters in various subcategories of hyperthyroid patients: a pilot study.
    Chouhan A; Abhyankar A; Basu S
    Nucl Med Commun; 2016 Jan; 37(1):74-8. PubMed ID: 26465804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.